Vnitr Lek 2022, 68(4):E04-E09 | DOI: 10.36290/vnl.2022.053

Recurrent urinary tract infections in kidney transplant patients with polycystic kidneys

Marcel Čellár1, Martina Konkoľová1, Eva Lacková1, Terézia Hrubá2, Peter Galajda3, Ivana Dedinská⁴
1 II. interná klinika, Slovenská zdravotnícka univerzita, Nefrologicko‑transplantačné oddelenie, Fakultná nemocnica s poliklinikou F. D. Roosevelta, Banská Bystrica
2 Oddelenie rádiológie, Fakultná nemocnica s poliklinikou F. D. Roosevelta, Banská Bystrica
3 I. interná klinika, Univerzitná nemocnica Martin a Jesseniova lekárska fakulta Univerzity Komenského ⁴Transplantačné centrum a I. interná klinika, Univerzitná nemocnica Martin a Jesseniova lekárska fakulta Univerzity Komenského

Introduction: Kidney transplantation is now a routine method used to treat end-stage renal disease. About 10 % of kidney transplant patients are patients with autosomal dominant polycystic kidney disease (ADPKD). After successful kidney transplantation, recurrent urinary tract infections also occur in initially asymptomatic patients.

Material and methods: The group included 320 patients after kidney transplantation. We compared patients with ADPKD versus patients without ADPKD in terms of the presence of recurrent urinary tract infections. The results: The incidence of recurrent urinary tract infections (rIMCs) was 18% in patients without ADPKD and 48% in patients without ADPKD. Nephrectomy after kidney transplantation due to recurrent urinary tract infections eliminated this infectious complication (in 86% of patients).

Conclusion: Kidney transplant patients with ADPKD have a significantly higher incidence of recurrent urinary tract infections. Removal of polycystic kidneys is a suitable solution if the infection persists.

Keywords: transplantation, kidneys, recurrent urinary tract infection, polycystic kidneys, ADPKD.

Published: June 22, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Čellár M, Konkoľová M, Lacková E, Hrubá T, Galajda P, Dedinská⁴ I. Recurrent urinary tract infections in kidney transplant patients with polycystic kidneys. Vnitr Lek. 2022;68(4):E04-09. doi: 10.36290/vnl.2022.053.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Kaballo MA, Canney M, O'Kelly P et al. A comparative analysis of survival of patients on dialysis and after kidney transplantation. Clin Kidney J 2018; 11(3): 389-393. Go to original source... Go to PubMed...
    2. Oxford handbook of nephrology and hypertension. 2nd ed. Oxford: Oxford Uni- versity Press (2014) s. 336, ISBN 978-0-19-965161-0.
    3. Chebib FT, Torres VE. Autosomal Dominant Polycystic Kidney Disease: Core Curriculum 2016. Am J Kidney Dis 2016; 67(5): 792-810. Go to original source... Go to PubMed...
    4. Teplan V et al. Praktická nefrologie, Praha: Grada Publishing 2006, ISBN 80-247-1122-2, 496 s.
    5. Stuart FP, Abecassis MM, Kaufman DB. Vademecum Organ Transplantation 2nd Edition, Georgetown: Landes Bioscience 2003, ISBN 1-57059-675-1, 810 s.
    6. Viklický O, Janoušek L, Baláž P. Transplantace ledviny v klinické praxi, Praha: Grada Publishing 2008, ISBN 978-80-247-2455-3, 384 s.
    7. Basu G. Infections After Kidney Transplantation: The Bug BEAR Of Kidney Transplantation in Tropics. The Open Urology & Nephrology Journal 2015; 8:76-87 Go to original source...
    8. Breza J, Žilinská Z et al. Transplantácia obličky, Ľubotice: Cofin, a. s. 2020, ISBN 978-80-973466-1-4, 289 s.
    9. Mitra S, Alangaden GJ. Reccurent Urinary Tract Infections in Kidney Transplant Recipients. Curr Infect Dis Rep 2011; 13: 579-587. Go to original source... Go to PubMed...
    10. Schiescher J. Reccurent UTIs After Renal Transplant. 2010, Dostupné na: http://www.renalandurologynews.com/recurrent‑utis‑after‑renal‑transplants/article/180801/#
    11. Spithoven E, Kramer A, Meijer E et al. Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival‑an analysis of data from the ERA‑EDTA Registry. Nephrol Dial Transplant 2014; 29: 15-25. Go to original source... Go to PubMed...
    12. Britt NS, Hagopian JC, Brennan DC et al. Effect of reccurent urinary tract infection on graft and patient outcomes after kidney transplantation. Nephrology Dialysis Transplantation 2017; 32, (10): 1758-1766. Go to original source... Go to PubMed...
    13. Feehally J, Floege J, Tonelli M. Comprehensive Clinical Nephrology Sixth Edition, Elsevier 2018, ISBN 978-0-323-47909-7, 1360 s.
    14. Rozanski J, Kozlowska I, Myslak M et al. Pretransplant nephrectomy in patient with autosomal dominat polycystic kidney disease. Transplant proc 2005; 37 (2): 666-668. Go to original source... Go to PubMed...
    15. Chapman AB, Devuyst O, Eckardt KU. Autosomal - dominant polycystic kidney disease (ADPKD): executive sumary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Published online 2015 Mar 18. doi: 10.1038/ki.2015.59, Dostupné na : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913350/ Go to original source...
    16. Teplan V et al. Praktická nefrologie, Praha: Grada Publishing 2006, ISBN 80-247-1122-2, 496 s.
    17. Torres VE, Chapman AB, Devuyst O et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med 2012; 367: 2255-2266. Go to original source... Go to PubMed...
    18. Torres VE, Chapman AB, Devuyst O et al. Multicentric, open label, extension trial to evaluate the long‑term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 trial. Nephrol Dial Transplant 2017; 32: 1262. Go to original source... Go to PubMed...
    19. Torres VE, Chapman AB, Devuyst O et al. Tolvaptan in later‑stage autosomal dominant polycystic kidney disease. N Engl J Med 2017; 377: 1930-1943. Go to original source... Go to PubMed...
    20. Veroux M, Zerbo D, Basile G et al. Simultaneous Native Nephrectomy and Kidney Transplantation in Patients With Autosomal Dominant Polycystic Kidney Disease. June 2016, Dostupné na WWW: https://doi.org/10.1371/journal.pone.0155481 Go to original source... Go to PubMed...
    21. Kirkman MA, Dellen D, Mehra S et al. Native nephrectomy for autosomal dominant polycystic disease: before or after kidney transplantation. December 2010, Dostupné na WWW: https://doi.org/10.1111/j.1464-410X.2010.09938.x Go to original source...
    22. Dedinská I, Laca L, Miklušica J et al. Diabetes mellitus after transplantation. Annals of transplantation research 2017; 1(1): 1005.
    23. Nowacka MP, Safranow K, Rózański, J et al. Autosomal Dominant Polycystic Kidney Disease Is Not a Risk For Post‑transplant Diabetes Mellitus. Matched‑pair Design Multicenred Study. Archives of medical research 2008; 39(3): 312-319. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.